PortfoliosLab logoPortfoliosLab logo
UTHR vs. FTNT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

UTHR vs. FTNT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in United Therapeutics Corporation (UTHR) and Fortinet, Inc. (FTNT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, UTHR achieves a 6.25% return, which is significantly lower than FTNT's 103.94% return. Over the past 10 years, UTHR has underperformed FTNT with an annualized return of 15.19%, while FTNT has yielded a comparatively higher 37.30% annualized return.


UTHR

1D
-1.54%
1M
-5.38%
6M
10.27%
YTD
6.25%
1Y
88.46%
3Y*
29.19%
5Y*
23.26%
10Y*
15.19%
ALL TIME*
17.35%

FTNT

1D
4.99%
1M
1.87%
6M
99.30%
YTD
103.94%
1Y
62.11%
3Y*
27.56%
5Y*
24.36%
10Y*
37.30%
ALL TIME*
31.37%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$952.63M$852.74M$900.80M
$217.22M$211.82M$269.54M

UTHR vs. FTNT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
UTHR
United Therapeutics Corporation
6.25%38.09%60.46%-20.93%28.70%42.35%72.33%-19.12%-26.39%3.15%
FTNT
Fortinet, Inc.
103.94%-15.95%61.42%19.72%-31.98%141.97%39.13%51.58%61.20%45.05%

Correlation

The correlation between UTHR and FTNT is -0.09, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

-0.09

Correlation (3Y)
Balances recent behavior with more history.

0.03

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.11

Correlation (10Y)
Provides a long-term view across more market conditions.

0.17

Correlation (All Time)
Calculated using the full available price history since Nov 18, 2009

0.23

The correlation between UTHR and FTNT shifts across timeframes, from -0.09 (1 year) to 0.23 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

UTHR:

$21.98B

FTNT:

$118.65B

EPS

UTHR:

$27.12

FTNT:

$2.83

PE Ratio

UTHR:

19.09

FTNT:

57.32

PEG Ratio

UTHR:

0.63

FTNT:

1.59

PS Ratio

UTHR:

7.75

FTNT:

16.15

PB Ratio

UTHR:

4.14

FTNT:

77.40

Total Revenue (TTM)

UTHR:

$3.17B

FTNT:

$7.53B

Gross Profit (TTM)

UTHR:

$2.74B

FTNT:

$6.05B

EBITDA (TTM)

UTHR:

$1.75B

FTNT:

$2.70B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

UTHR vs. FTNT — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

UTHR
UTHR Risk / Return Rank: 9595
Overall Rank
UTHR Sharpe Ratio Rank: 9191
Sharpe Ratio Rank
UTHR Sortino Ratio Rank: 9898
Sortino Ratio Rank
UTHR Omega Ratio Rank: 9696
Omega Ratio Rank
UTHR Calmar Ratio Rank: 9797
Calmar Ratio Rank
UTHR Martin Ratio Rank: 9696
Martin Ratio Rank

FTNT
FTNT Risk / Return Rank: 8181
Overall Rank
FTNT Sharpe Ratio Rank: 8383
Sharpe Ratio Rank
FTNT Sortino Ratio Rank: 7777
Sortino Ratio Rank
FTNT Omega Ratio Rank: 8383
Omega Ratio Rank
FTNT Calmar Ratio Rank: 8484
Calmar Ratio Rank
FTNT Martin Ratio Rank: 7676
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

UTHR vs. FTNT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for United Therapeutics Corporation (UTHR) and Fortinet, Inc. (FTNT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


UTHRFTNTDifference
Sharpe ratioReturn per unit of total volatility

+0.52

Sortino ratioReturn per unit of downside risk

+2.45

Omega ratioGain probability vs. loss probability

1.49

1.29

+0.20

Calmar ratioReturn relative to maximum drawdown

6.71

2.55

+4.17

Martin ratioReturn relative to average drawdown

15.67

4.11

+11.56

UTHR vs. FTNT - Sharpe Ratio Comparison

The current UTHR Sharpe Ratio is 1.89, which is higher than the FTNT Sharpe Ratio of 1.37. The chart below compares the historical Sharpe Ratios of UTHR and FTNT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

UTHR vs. FTNT - Drawdown Comparison

The maximum UTHR drawdown since its inception was -93.18%, which is greater than FTNT's maximum drawdown of -51.20%. Use the drawdown chart below to compare losses from any high point for UTHR and FTNT.


Loading charts...

Drawdown Indicators


UTHRFTNTDifference

Max Drawdown

Largest peak-to-trough decline

-93.18%

-51.20%

-41.98%

Max Drawdown (1Y)

Largest decline over 1 year

-13.25%

-24.52%

+11.27%

Max Drawdown (3Y)

Largest decline over 3 years

-33.00%

-35.07%

+2.07%

Max Drawdown (5Y)

Largest decline over 5 years

-33.00%

-38.32%

+5.32%

Max Drawdown (10Y)

Largest decline over 10 years

-55.56%

-38.32%

-17.24%

Current Drawdown

Current decline from peak

-13.25%

-2.93%

-10.32%

Average Drawdown

Average peak-to-trough decline

-35.18%

-16.12%

-19.06%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.66%

16.09%

-10.43%

Volatility

UTHR vs. FTNT - Volatility Comparison

The current volatility for United Therapeutics Corporation (UTHR) is 6.09%, while Fortinet, Inc. (FTNT) has a volatility of 11.57%. This indicates that UTHR experiences smaller price fluctuations and is considered to be less risky than FTNT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


UTHRFTNTDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.09%

11.57%

-5.48%

Volatility (6M)

Calculated over the trailing 6-month period

25.86%

32.98%

-7.12%

Volatility (1Y)

Calculated over the trailing 1-year period

47.15%

45.60%

+1.55%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

35.05%

44.22%

-9.17%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

34.89%

40.85%

-5.96%

Dividends

UTHR vs. FTNT - Dividend Comparison

Neither UTHR nor FTNT has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

UTHR vs. FTNT - Financials Comparison

This section allows you to compare key financial metrics between United Therapeutics Corporation and Fortinet, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

UTHR vs. FTNT - Profitability Comparison

The chart below illustrates the profitability comparison between United Therapeutics Corporation and Fortinet, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

UTHR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, United Therapeutics Corporation reported a gross profit of 648.10M and revenue of 781.50M. Therefore, the gross margin over that period was 82.9%.

FTNT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Fortinet, Inc. reported a gross profit of 1.64B and revenue of 2.05B. Therefore, the gross margin over that period was 80.2%.

UTHR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, United Therapeutics Corporation reported an operating income of 325.80M and revenue of 781.50M, resulting in an operating margin of 41.7%.

FTNT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Fortinet, Inc. reported an operating income of 689.30M and revenue of 2.05B, resulting in an operating margin of 33.7%.

UTHR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, United Therapeutics Corporation reported a net income of 274.90M and revenue of 781.50M, resulting in a net margin of 35.2%.

FTNT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Fortinet, Inc. reported a net income of 606.30M and revenue of 2.05B, resulting in a net margin of 29.6%.


Frequently Asked Questions


UTHR and FTNT have a correlation of -0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

FTNT has higher volatility (11.57%) compared to UTHR (6.09%). In terms of maximum drawdown, UTHR dropped -93.18% vs FTNT's -51.20%.

UTHR currently has the higher Sharpe Ratio (1.89 vs 1.37), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for UTHR and FTNT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer